Chemotherapeutic agents that inhibit neutrophil biogenesis (6) (7) (8) and/or reduce their bactericidal activity (7) produce neutropenia (i.e., <500,000 neutrophils/ml blood). Although neutropenia predisposes to infection, it has little direct effect on the sterility of blood because under most (9) -but not all (10) -conditions, hepatic and splenic macrophages are the cells primarily responsible for clearing bacteria from the circulation. Indeed, as suggested by Crosby (11) and supported by the studies of Wright et al. (12) and Koene et al. (13), it is the tissue neutrophil concentration (N) that determines whether the small number of bacteria that breech mucosal surfaces each day will find fertile soil for growth, or be engulfed and killed. Thus, while a blood N value of 5 × 10 5 neutrophils/ml is a call for vigilance, it is an imprecise measure of the likelihood of infection. This is so because blood is primarily the conduit by which neutrophils travel from bone marrow to tissues, and the blood N reflects the sum of the rates at which neutrophils are produced and released from bone marrow into the circulation, and the rates at which they are consumed in tissues (14) and/or recycled to spleen and bone marrow for destruction (15) .
can explore approximately 20 pl medium/ min, whereas in rabbit dermis, it can only explore approximately 4 pl dermis/min. Accordingly, 5 × 10 6 neutrophils/ml -the average concentration in human blood -is required for these cells to explore 1 ml of a stirred bacterial suspension in 10 minutes (i.e., 2 × 10 -8 ml/neutrophil/min × 5 × 10 6 neutrophils × 10 min = 1 ml). Likewise, N of 2.5 × 10 7 neutrophils/ml or neutrophils/g rabbit dermis is required for neutrophils to explore 1 milliliter or gram of dermis in 10 minutes. Higher concentrations of neutrophils or longer exploration times are required when B exceeds 10 7 per milliliter stirred suspension (21) or 10 6 per milliliter or gram of tissue (20) .
Dynamic system model of neutrophil bactericidal activity: effects of bistability The equation Malka et al. report here (25) and previously (26) 
, more accurately describes the rate of bacterial clearance than does the one previously reported by Li et al. (20, 21) . This is because Malka et al. included the saturation rate for bacterial growth (β) and the spontaneous rate of bacterial death [δB(t)]. The bacterial growth rate (ρ) behaves like a carrying capacity and saturates (βB) at high B values. The authors also included in their equation the rates of bacterial influx into the circulation or site of infection(s) and of spontaneous bacterial death. If these rates could be measured, their inclusion would add significantly to the predictive power of the equation; however, there are no established methods at present for measuring them. Hence, Malka et al. assign them a value of 0, thereby eliminating this difference between the two groups' equations.
They discovered that neutrophil-bactericidal activity in dermis of living rabbits and in fibrin gels is controlled by N and is independent of bacterial concentration (B), up to approximately 10 6 CFU/ml (20) . They derived an equation that describes bacterial killing as a function of N and bacterial growth rate ( Figure 1A ) and showed that it accurately described neutrophil-bactericidal activity in suspension (21), fibrin gels, and dermis of living rabbits (20) . Additionally, they found the ratio of the experimentally determined bacterial growth rate (g) and neutrophil-bacterial killing rate constant (k) defined a new and extremely useful parameter: the critical neutrophil concentration (CNC), namely, the N required to hold B constant ( Figure 1A and refs. 20, 21 ).
At N values below the CNC, B increases; at N above the CNC, B decreases. The CNC in stirred suspensions is approximately 4 × 10 5 neutrophils/ml (21), very close to the clinically determined value of 5 × 10 5 neutrophils/ml that defines neutropenia and characterizes neutropenic patients in danger of infection (6) (7) (8) . The CNC in fibrin gels and rabbit dermis is approximately 1 × 10 6 and 8 × 10 6 neutrophils/ml, respectively (20) , 2-to 20-fold larger than in stirred suspensions. Apparently, evolution has taken note of the CNC, as the blood neutrophil concentration is no less than approximately 5 × 10 5 neutrophils/ml in all adult vertebrates (22) (23) (24) .
What is the physical meaning of the CNC? The answer is evident from the value and units of k (ml/neutrophil/min), which for these purposes can be viewed as the volume of medium or tissue a neutrophil can explore per minute. For neutrophils in stirred suspension and in dermis of living rabbits, k is equivalent to 2 × 10 -8 and 4 × 10 -9 ml/neutrophil/min, respectively. In stirred suspension, 1 neutrophil A critical concentration of neutrophils is required to produce a net reduction in bacterial concentration Since Robertson and Sia's 1924 report (16) , most in vitro studies of neutrophil-bactericidal activity have used neutrophils stirred continuously for 15-120 minutes at 37°C in plasma-or serum-containing medium with known concentrations of bacteria. The neutrophils then are lysed, and the concentration of viable bacteria remaining is measured by bacteriological colony assay. This system mimics neutrophil-bactericidal activity in blood. Comparatively few investigators have studied neutrophil-bactericidal activity in tissues of living animals or in three-dimensional gels composed of extracellular matrix proteins. The findings that extracellular matrix proteins exert potent physiological effects on phagocytes (17, 18) , and that the chemoattractant N-formyl-methionine-leucine-phenylalanine (fMLP) (19) inhibits neutrophil migration in fibrin-containing matrices, but not in collagen matrices, prompted Li et al. to examine neutrophil-bactericidal activity in tissues and tissue-like environments (20) . (20, 21) . It predicts the CNC is constant at all B values. Their experiments show, however, that the bacterial growth rate and killing constant decrease, and the CNC increases (curved dashed line), at B values greater than 10 7 CFU/ml in stirred suspension and greater than 10 6 CFU/ml in fibrin gel (not shown). Most importantly, this equation predicts B will decrease or increase at all N values below or above the CNC, respectively, and remain constant at the CNC. (B) In contrast, as reported here by Malka et al., the bacterial population is bistable at N at or very near the CNC, creating favorable conditions for uncontrolled bacterial growth (25) . N1 and N2 and the dashed line indicate the N and B values that define the zone of bistability in the bacterial population. For N below the CNC (solid yellow line), the bacterial population grows exponentially. Note also that in fibrin gels and rabbit dermis, the CNC at all N values is at least 2-fold larger than in stirred suspensions, a reflection of the effect of the former environment on the bacterial killing constant.
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. Thus, the method Malka et al. use might better predict the likelihood of infection in neutropenic patients if it employed fibrin gels to determine their neutrophils' bactericidal activity. Li et al. showed that the kinetics of neutrophilbactericidal activity in these gels closely mimics that for neutrophils in tissues in vivo (20) . Third, Malka et al. ascribed the variability they observed in killing of S. aureus to differences in bactericidal activity of neutrophils from different healthy adult donors (25) . However, their studies used 10% autologous serum, close to the concentration at which opsonin concentration becomes limiting (21, 27); 20%-40% serum would have been a better choice (21) . Moreover, Malka et al. did not control for variations in opsonin concentration in each leukocyte donor's serum. Thus, the variations in killing efficiencies observed could reflect variations in serum opsonin concentrations (27, 28) , not in neutrophil bactericidal activity. From both mechanistic and practical standpoints, this is an important matter to resolve.
Clinical experience now suggests that the use of G-CSF to prevent bone marrow-depressive effects of chemotherapy in patients at high risk for neutropenia is far more efficacious than using it to treat neutropenia once it has occurred (8, 29) . Accordingly, it may be that the most useful clinical application of this new equation will be to use it prospectively in conjunction with other predictive tools (29) , including low-tech methods such as the one devised by Wright et al. (12) , to assess the likelihood that chemotherapy will cause the tissue bactericidal activity of a patient's neutrophils to fall below the CNC and/or into regions of bacterial bistability.
These concerns notwithstanding, we believe the findings that neutrophil-bactericidal activity can be described by equations very similar to those describing enzymesubstrate interactions provide an entirely new and quantitative way of viewing cellular defense against microbial pathogens. Budhu et al. reported that the equation described by Li et al. (21) also describes antigen-specific CD8 + T cell killing of cognate antigen-expressing melanoma cells in vitro and in living mice (30) , which suggests that the same physical principles that govern neutrophil-bacterial interactions also govern the interactions of cytolytic lymphocytes with eukaryotic target cells. Indeed, it seems likely that these principles govern The equation's quadratic term represents the killing rate (-αNB(t)/[1 + γB(t) + ηN]). It involves the law of mass action: the neutrophil-bactericidal rate is proportional (α) to the product of N and B multiplied by the amount of time (t; in minutes) the neutrophils interact with bacteria. It saturates at high concentrations of both neutrophils (ηN) and bacteria (γB). The system yields two very different outcomes depending on the magnitude of the initial parameters: it is monostable when N is well above or below the critical concentration, but becomes bistable when N fluctuates close to the CNC. Bistability is a characteristic of dynamic systems in which two stable coexisting fixed points exist for a range of parameters ( Figure 1B) , and the system's outcome depends on its initial conditions.
Unresolved questions
Although the equation derived by Malka et al. (25, 26) provides a more complete description of neutrophil-bactericidal activity than that of Li et al. (21) , additional experiments are needed to assess its clinical utility. First, the conclusion that there is substantial patient-topatient variability in neutrophil-bactericidal activity relies on studies of the staphylococcicidal activity of neutrophils from only four healthy adults (25) . Li et al. observed an approximately 2-fold variation in values of k and CNC for neutrophils from more than 20 healthy adult donors killing S. epidermidis in stirred solutions (21) , and variations in these parameters of similar magnitude for neutrophils killing S. aureus, E. coli, and P. aeruginosa in stirred suspensions in studies are reported by others. Variations in neutrophil-bactericidal activity of this magnitude near or at the CNC are certainly sufficient to produce bistability in the bacterial population. Nonetheless, additional measurements of the efficiency of killing of both Gram-positive and -negative bacteria by neutrophils, from a larger number of uninfected and infected eupenic and neutropenic donors than was tested by Malka et al., are needed to define precisely the frequency and magnitude of variation in bactericidal activity of neutrophils. Second, the authors measured neutrophil-bactericidal activity in stirred suspensions (25) , a condition that mimics neutrophil-bactericidal activity in blood. However, neutrophilbactericidal activity in tissues is of greatest relevance for neutropenic patients (8, 
